[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hemorrhoid-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hemorrhoid-pain":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,49,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100615690","topical-nifedipine-03-plus-lidocaine-15-for-uncomplicated-hemorrhoidal-disease-100615690",false,"NCT07295886","Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease","Observational Study on the Use of Topical Nifedipine 0.3% and Lidocaine 1.5% in Acute Uncomplicated Hemorrhoidal Disease","NILOS","Inclusion Criteria:\n\n* Male and female patients aged 18-75 years.\n* Clinical or anoscopic diagnosis of acute hemorrhoidal disease with prolapse severity between Grade II and IV (Goligher), possibly associated with external congestion.\n* Patients who started treatment with nifedipine 0.3% + lidocaine 1.5% within the past 5 days.\n* Availability of clinical evaluations at treatment initiation (proctologic visit and HDSS, SHS-HD, VAS scales).\n* Ability to understand the informed consent.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Acute hemorrhoidal disease complicated by thrombosis or strangulation.\n* Coagulopathies.\n* Active neoplastic disease.\n* Treatment with anticoagulants and\u002For chemotherapeutic agents.\n* Hypersensitivity to active substances, especially lidocaine (and other amide-type local anesthetics) or excipients.\n* Severe hypotensive states or cardiovascular insufficiency.\n* Pregnancy or breastfeeding.\n* Participation in clinical trials involving investigational drugs.","ALL","18 Years","75 Years",{"count":21,"type":22},80,"ESTIMATED","30 Days","OBSERVATIONAL","The goal of this observational study is to evaluate the effectiveness of topical nifedipine 0.3% plus lidocaine 1.5% for uncomplicated hemorrhoidal disease. The main question it aims to answer is:\n\nDoes topical nifedipine 0.3% plus lidocaine 1.5% lower symptoms in patients with uncomplicated acute hemorrhoidal disease? Participants already taking nifedipine 0.3% plus lidocaine 1.5% as part of their regular medical care for hemorrhoidal disease will undergo four visits over a 30-day period, including two telephone contacts and two in-person visits.",[27,28,29,30,31],"Hemorrhoid Bleeding","Hemorrhoids Prolapse","Hemorrhoid Pain","Hemorrhoid","Topical Administration",[33,34,35],"nifedipine 0.3% plus lidocaine 1.5%","uncomplicated hemorrhoidal disease","hemorrhoids symptoms","RECRUITING","2025-12-19",{"date":39,"type":40},"2025-12-22","ACTUAL",{"date":42,"type":40},"2025-09-02",{"date":44,"type":22},"2026-05-02",{"name":46,"class":47},"Cardarelli Hospital","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":4},"100611278","acupuncture-for-post-hemorrhoidectomy-pain-control-100611278","NCT07238504","Acupuncture for Post-hemorrhoidectomy Pain Control","Acupuncture for Post-hemorrhoidectomy Pain Control With Acute Anti-inflammatory Effects: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Symptomatic grade III or IV hemorrhoids undergoing conventional hemorrhoidectomy\n\nExclusion Criteria:\n\n1. Patients scheduled for stapled hemorrhoidopexy\n2. Concomitant surgery other than conventional hemorrhoidectomy\n3. Bleeding tendency, thrombocytopenia (platelet count \\\u003C 100 x 10\\^9\u002FL)\n4. Immunocompromised status or use of chemotherapy\n5. Active dermatitis\n6. Patients with pacemaker or automated implantable cardioverter-defibrillator\n7. Pregnant patients\n8. Known allergy to opioids, local anaesthetic drugs, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDS) including cyclooxygenase-2 inhibitors\n9. History of chronic pain (duration for 3 months or more)\n10. Daily use of strong opioids (e.g. morphine, fentanyl, hydromorphone, methadone, oxycodone, or meperidine)\n11. Alcohol or drug abuse\n12. Psychiatric illness\n13. Impaired renal function (preoperative serum creatinine level \\> 120µmol\u002FL)\n14. Recent acupuncture treatment for other medical conditions","90 Years",{"count":58,"type":22},100,"INTERVENTIONAL",[61],"NA","The goal of this clinical trial is to learn if acupuncture improves pain control after hemorrhoidectomy in patients with symptomatic hemorrhoids. It will also learn about the safety of using acupuncture in surgical patients. The main questions it aims to answer are:\n\nDoes acupuncture lower the maximal pain intensity after hemorrhoidectomy? Does acupuncture reduce analgesics requirement, length of hospital stay and quality of recovery?\n\nResearchers will compare fully active acupuncture to a sham treatment (a look-alike procedure with minimum acupuncture stimulation) to see if active acupuncture works to improve pain control.\n\nParticipants will:\n\nReceive acupuncture treatment for 7 times over first 5 days after surgery. Visit the clinic once 2 weeks after surgery for checkups and tests. Keep a diary of their symptoms and the number of times they take pain-killers.",[64,29,65],"Hemorrhoidectomy","Acupuncture","NOT_YET_RECRUITING","2025-11-24",{"date":69,"type":40},"2025-12-02",{"date":71,"type":22},"2026-03",{"date":73,"type":22},"2027-04",{"name":75,"class":47},"The University of Hong Kong",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":84,"sex":17,"minAge":18,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":59,"phases":88,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":48},"100557219","postoperative-pain-in-the-surgical-treatment-of-hemorrhoids-conventional-hemorrhoidectomy-with-a-monopolar-electric-scaler-vs-bipolar-energy-with-caiman-aesculap-100557219","NCT06535269","Postoperative Pain in the Surgical Treatment of Hemorrhoids: Conventional Hemorrhoidectomy With a Monopolar Electric Scaler VS Bipolar Energy With Caiman® (Aesculap®)","Prospective Randomized Study on Postoperative Pain in the Surgical Treatment of Hemorrhoids Through Conventional Hemorrhoidectomy With a Monopolar Electric Scalpel or Bipolar Energy With Caiman® (Aesculap®)","TAUHEMOR","Inclusion Criteria:\n\n* All patients with 2 or 3 bundles of grade III-IV hemorrhoids (Goligher classification) clinically symptomatic and subject to outpatient hemorrhoidectomy\n* Voluntary participation.\n* ASA I-II-III.\n\nExclusion Criteria:\n\n* Failure to meet the inclusion criteria.\n* ASA IV.\n* Allergic to Paracetamol, derivatives of morphine.\n* Allergic to NSAIDs.\n* Synchronous colorectal neoplasia.\n* Coagulation disorders.\n* Thrombosed hemorrhoid.\n* Inflammatory bowel disease.\n* Liver cirrhosis and\u002For portal hypertension.\n* Pregnant women.\n* Difficulty following up by phone and\u002For in person.",true,"65 Years",{"count":87,"type":22},27,[61],"To demonstrate that postoperative pain secondary to Milligan and Morgan hemorrhoidectomy with Caiman® (AESCULAP®) and subsequent oral conventional analgesia is at least not greater than that generated after hemorrhoidectomy with monopolar diathermy and intravenous analgesia with care home at discharge.",[29,64],"2024-08-01",{"date":93,"type":40},"2024-08-02",{"date":95,"type":40},"2022-11-02",{"date":97,"type":22},"2025-07",{"name":99,"class":47},"Corporacion Parc Tauli"]